-
Cynosure Targets Raised At Northland Capital On Potential Vaginal Atrophy Treatment
Thursday, June 25, 2015 - 3:21pm | 337In a report issued Thursday, Northland Capital Markets analyst Suraj Kalia reiterated an Outperform rating on Cynosure, Inc. (NASDAQ: CYNO), while raising his price target from $42 to $46. The surge in the price target was driven by the firm’s sum of the parts analysis on the MonaLisa...